东诚药业
(002675)
| 流通市值：94.71亿 | | | 总市值：105.05亿 |
| 流通股本：7.43亿 | | | 总股本：8.25亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 1,935,009,382.82 | 1,308,921,449.19 | 626,367,330.36 | 2,741,074,183.83 |
| 营业总成本 | 1,739,183,400.19 | 1,180,863,080.35 | 577,283,980.83 | 2,521,698,364.08 |
| 其他经营收益 | | | | |
| 营业利润 | 213,543,405.14 | 124,641,928.53 | 48,584,595.09 | 212,638,764.73 |
| 利润总额 | 210,318,664.4 | 124,647,888.82 | 48,406,137.03 | 211,442,575.58 |
| 净利润 | 153,941,959.51 | 82,993,349.34 | 34,867,172.49 | 154,441,271.11 |
| 每股收益 | | | | |
| 其他综合收益 | -39,386,593.86 | -30,675,085.83 | -15,147,336.34 | -566,212.92 |
| 综合收益总额 | 114,555,365.65 | 52,318,263.51 | 19,719,836.15 | 153,875,058.19 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 2,562,502,400.76 | 2,565,426,766.15 | 2,613,889,566.47 | 2,684,935,912.33 |
| 非流动资产: | | | | |
| 非流动资产合计 | 6,536,300,156.08 | 6,639,666,094.99 | 6,565,078,218.59 | 6,538,825,863.81 |
| 资产总计 | 9,098,802,556.84 | 9,205,092,861.14 | 9,178,967,785.06 | 9,223,761,776.14 |
| 流动负债: | | | | |
| 流动负债合计 | 1,711,965,376.63 | 1,771,953,209.69 | 1,531,092,539.69 | 1,636,007,566.04 |
| 非流动负债: | | | | |
| 非流动负债合计 | 2,106,428,918.1 | 2,100,711,885.73 | 2,243,468,084.68 | 2,124,049,223.47 |
| 负债合计 | 3,818,394,294.73 | 3,872,665,095.42 | 3,774,560,624.37 | 3,760,056,789.51 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 4,451,505,982.11 | 4,398,152,673.51 | 4,286,341,387.78 | 4,350,054,961.75 |
| 股东权益合计 | 5,280,408,262.11 | 5,332,427,765.72 | 5,404,407,160.69 | 5,463,704,986.63 |
| 负债和股东权益合计 | 9,098,802,556.84 | 9,205,092,861.14 | 9,178,967,785.06 | 9,223,761,776.14 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 2,050,357,005.33 | 1,263,021,454.85 | 628,686,385.29 | 2,879,154,143.36 |
| 经营活动现金流出小计 | 1,793,959,881.14 | 1,200,736,091.12 | 660,084,916.82 | 2,299,303,748.9 |
| 经营活动产生的现金流量净额 | 256,397,124.19 | 62,285,363.73 | -31,398,531.53 | 579,850,394.46 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 645,106,757.6 | 447,462,500.23 | 262,343,044.37 | 1,151,461,823.44 |
| 投资活动现金流出小计 | 1,360,644,472.9 | 1,058,822,810.84 | 282,296,959.11 | 1,706,136,211.22 |
| 投资活动产生的现金流量净额 | -715,537,715.3 | -611,360,310.61 | -19,953,914.74 | -554,674,387.78 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 1,018,239,726.73 | 912,985,648.92 | 161,889,298.6 | 928,226,113.98 |
| 筹资活动现金流出小计 | 673,872,386.61 | 531,863,480.23 | 161,923,441.83 | 841,905,373.98 |
| 筹资活动产生的现金流量净额 | 344,367,340.12 | 381,122,168.69 | -34,143.23 | 86,320,740 |
| 汇率变动对现金及现金等价物的影响 | -7,075,884.06 | -4,394,515.87 | -2,501,209.53 | -2,391,921.44 |
| 现金及现金等价物净增加额 | -121,849,135.05 | -172,347,294.06 | -53,887,799.03 | 109,104,825.24 |
| 期末现金及现金等价物余额 | 722,876,255.27 | 672,378,096.26 | 793,191,007.2 | 844,725,390.32 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -172,347,294.06 | - | 109,104,825.24 |
最新报告期：2026-11-02| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 东吴证券 | 刘若彤,朱国广 | 0.25 | 0.34 | 0.44 | 2026-11-02 |
| 天风证券 | 杨松 | 0.24 | 0.31 | 0.38 | 2026-09-08 |
| 平安证券 | 叶寅,韩盟盟 | 0.27 | 0.37 | 0.50 | 2026-08-24 |